<TABLE> <S> <C>
<ARTICLE> 5
<LEGEND>
THIS SCHEDULE CONTAINS SUMMARY FINANCIAL INFORMATION EXTRACTED FROM THE
UNAUDITED INTERIM FINANCIAL STATEMENTS INCLUDED IN THE REGISTRANT'S FORM 10-QSB
FOR THE PERIOD ENDED JUNE 30, 2000 AND IS QUALIFIED IN ITS ENTIRETY BY
REFERENCE TO SUCH FINANCIAL STATEMENTS.
</LEGEND>
<CIK> 0000822418
<NAME> Bio-Imaging Technologies, Inc.
<MULTIPLIER> 1
<CURRENCY> U.S. Dollars
<S> <C>
<PERIOD-TYPE> 9-MOS
<FISCAL-YEAR-END> SEP-30-2000
<PERIOD-START> OCT-01-1999
<PERIOD-END> JUN-30-2000
<EXCHANGE-RATE> 1
<CASH> 134,464
<SECURITIES> 0
<RECEIVABLES> 2,273,906
<ALLOWANCES> 65,000
<INVENTORY> 0
<CURRENT-ASSETS> 2,561,436
<PP&E> 3,165,541
<DEPRECIATION> 1,782,580
<TOTAL-ASSETS> 4,172,143
<CURRENT-LIABILITIES> 2,685,696
<BONDS> 207,655
0
104
<COMMON> 1,944
<OTHER-SE> 1,276,744
<TOTAL-LIABILITY-AND-EQUITY> 4,172,143
<SALES> 0
<TOTAL-REVENUES> 4,105,911
<CGS> 0
<TOTAL-COSTS> 2,705,862
<OTHER-EXPENSES> 2,102,586
<LOSS-PROVISION> 0
<INTEREST-EXPENSE> 54,831
<INCOME-PRETAX> (757,368)
<INCOME-TAX> 0
<INCOME-CONTINUING> (757,368)
<DISCONTINUED> 0
<EXTRAORDINARY> 0
<CHANGES> 0
<NET-INCOME> (757,368)
<EPS-BASIC> (0.10)
<EPS-DILUTED> (0.10)
</TABLE>